InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Ajer Jeffrey Robert, Directeur et Directeur Exécutif Commercial. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. In total, 22 filings have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €1.2m. Activity tracked since 22 September 2021. The latest transaction was filed on 30 April 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ajer Jeffrey Robert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
300 shares@ US$68.6460.3% of flowCommon StockSEC:0001048477-24-000073:0
22,580 shares@ US$83.8726.3% of flowCommon StockSEC:0001048477-24-000036:0
4,000 shares@ US$87.074.9% of flowCommon StockSEC:0001048477-24-000030:0
21,440 shares0Common StockSEC:0001048477-24-000022:0
4,359 shares@ US$0.6917.3% of flowCommon StockSEC:0001209191-23-050220:0
318 shares@ US$66.8780.3% of flowCommon StockSEC:0001048477-23-000039:0
10,110 shares0Common StockSEC:0001567619-23-005283:0
20,760 shares0Common StockSEC:0001209191-23-014609:0
49,000 shares@ US$67.8146.2% of flowCommon StockSEC:0001567619-23-001396:0
3,000 shares@ US$86.124.0% of flowCommon StockSEC:0001567619-22-019207:0
4,198 shares@ US$3.1682.7% of flowCommon StockSEC:0001209191-22-051304:0
10,200 shares0Common StockSEC:0001209191-22-050808:0
3,000 shares@ US$95.624.2% of flowCommon StockSEC:0001567619-22-015887:0
7,021 shares@ US$77.497.7% of flowCommon StockSEC:0001567619-22-012432:0
340 shares@ US$62.4070.3% of flowCommon StockSEC:0001567619-22-011966:0
1,180 shares@ US$82.471.4% of flowCommon StockSEC:0001567619-22-008576:0
1,618 shares@ US$79.431.8% of flowCommon StockSEC:0001567619-22-007808:0
2,073 shares@ US$81.002.3% of flowCommon StockSEC:0001567619-22-007460:0
11,940 shares0Common StockSEC:0001567619-22-007177:0
9,370 shares0Common StockSEC:0001567619-22-006713:0
342 shares@ US$62.4070.3% of flowCommon StockSEC:0001567619-21-018936:0
10,200 shares0Common StockSEC:0001209191-21-057702:0
22 of 22 declarations
About Ajer Jeffrey Robert
Ajer Jeffrey Robert is Director et Directeur Exécutif Commercial. He has 22 filings in total, and across the recent filings covered, sales amount to EUR 1,234,329, with dates from 2021-09-24 to 2024-05-06. His listed companies are Biomarin Pharmaceutical INC, where he is EVP, Chief Commercial Officer, and NEKTAR THERAPEUTICS, where he is Director.
